Clinical Characteristics and Biopsy Specimen Features in African-American and White Men Without Prostate Cancer

• Published in: JNCI : Journal of the National Cancer Institute Vol. 90; no. 10; pp. 756 - 760
• Main Authors: Eastham, James A., May, Robert A., Whatley, Terence, Crow, Arden, Venable, Dennis D., Sartor, Oliver
• Format: Journal Article
• Language: English
• Published: Cary, NC Oxford University Press 20-05-1998; Oxford Publishing Limited (England)
• Subjects: Aged; Biological and medical sciences; Biopsy, Needle; Black or African American; Black People; Clinical trials; Humans; Male; Medical sciences; Men; Middle Aged; Nephrology. Urinary tract diseases; Prostate - anatomy & histology; Prostate - pathology; Prostate cancer; Prostate-Specific Antigen - blood; Testosterone - blood; Tumors of the urinary system; Urinary tract. Prostate gland; White People; Human; Urinary system disease; Prostate disease; Negroid; Male; Tumoral marker; Malignant tumor; Epidemiology; Prostate specific antigen; Adult; Caucasoid; Male genital diseases; Prostate; Comparative study
• ISSN: 0027-8874; 1460-2105
• DOI: 10.1093/jnci/90.10.756

The reported incidence of prostate cancer is higher among African-American men than among white men. We conducted a study of African-American and white men without prostate cancer to determine whether clinical and histologic findings might be associated with racial differences in serum prostate-specific antigen (PSA) levels.
From January 1990 through March 1997, 493 (59.5%) of 829 African-American men and 736 (74.1%) of 993 white men who had elevated serum PSA levels (> or = 4.0 ng/mL) and/or abnormal digital rectal examinations and who underwent transrectal ultrasound-guided prostate biopsies were found to be without prostate cancer. Also reviewed were patients' age and race, indication for biopsy, histologic features of the prostate biopsy specimen, ultrasound-measured prostate volume, PSA density (i.e., the PSA level divided by the prostate volume), and (in some cases) serum testosterone levels.
Among these men without prostate cancer, there were no statistically significant differences by race in the ages of the patients, their prostate volumes, or their serum testosterone levels; however, the mean serum PSA levels and PSA densities were significantly higher in African-American men than in white men (two-sided P values of .00003 and .000009, respectively). A higher proportion of African-American men than white men had inflammation in their prostate biopsy specimen, and men of both races with prostate inflammation had higher PSA values than those without inflammation. African-American men without inflammation had higher PSA values than white men without inflammation.
In this study, African-American men without histologic evidence of prostate cancer had significantly higher PSA levels and PSA densities than similarly aged white men. This finding was not accounted for by racial differences in patients' age, serum testosterone level, or prostate volume.